Executive Summary GLP-1RA (Glucagon-like peptide-1 receptor agonist) drugs that help regulate blood sugar levels have been around for close to 20 years and are primarily used in diabetes treatment. However, they have garnered never-before-seen levels of medical, media and business attention over the last few months, following the announcement of…
Anti-diversity, equity and inclusion (DEI) activity is not new, but it is intensifying, having been emboldened by the Supreme Court ruling on Affirmative Action in higher education and the divisive nature of current politics and policy. Corporations are navigating lawsuits, retraction letters, calls for EEOC investigations and…